Clinical Trial Update: Beta-sitosterol for Subarachnoid Hemorrhage: Mechanistic Analysis of Recovery and Therapy [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 clinical trial evaluating beta-sitosterol for recovery after subarachnoid hemorrhage, with mechanistic analyses of treatment effects. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• Beta-sitosterol (beta-sitosterol)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Subarachnoid Haemorrhagic Stroke | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION